| scholarly article | Q13442814 |
| P50 | author | Jean-Patrice Baillargeon | Q41112003 |
| P2093 | author name string | John E Nestler | |
| Jean-Patrice Baillargeon | |||
| Maria J Iuorno | |||
| Teimuraz Apridonidze | |||
| P2860 | cites work | Phospholipase C mimics insulin action on pyruvate dehydrogenase and insulin mediator generation but not glucose transport or utilization | Q43579794 |
| Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women | Q43927173 | ||
| G(q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of G(q/11) with the insulin receptor in membrane vesicles | Q44084679 | ||
| Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome | Q44723070 | ||
| A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome | Q44942757 | ||
| Effects of a reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulfate in nondiabetic men. | Q45088935 | ||
| Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study | Q46299275 | ||
| Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction | Q46938213 | ||
| Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. | Q51558724 | ||
| Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. | Q51558919 | ||
| Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. | Q51561183 | ||
| Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. | Q52719647 | ||
| In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat. | Q54131435 | ||
| Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. | Q54189909 | ||
| Asymmetric distribution of the phosphatidylinositol-linked phospho-oligosaccharide that mimics insulin action in the plasma membrane | Q62132734 | ||
| Insulin mediators in man: effects of glucose ingestion and insulin resistance | Q73370588 | ||
| Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome | Q28142499 | ||
| Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls | Q28202966 | ||
| Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome | Q28271889 | ||
| Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome | Q28294415 | ||
| In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues | Q30311460 | ||
| Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells | Q30452997 | ||
| Insulin stimulates the biosynthesis of chiro-inositol-containing phospholipids in a rat fibroblast line expressing the human insulin receptor | Q30454048 | ||
| Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus | Q30456702 | ||
| Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol. | Q30460806 | ||
| Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone | Q31924533 | ||
| Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial | Q33979209 | ||
| Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial | Q34011558 | ||
| Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). | Q34285382 | ||
| Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome | Q34473103 | ||
| Insulin sensitizers for polycystic ovary syndrome | Q35155109 | ||
| Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome | Q35564923 | ||
| Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome | Q35893431 | ||
| Use of insulin sensitizers in polycystic ovarian syndrome. | Q36301404 | ||
| Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? | Q36303511 | ||
| The metabolic syndrome in polycystic ovary syndrome | Q36472269 | ||
| D-chiro-inositol metabolism in diabetes mellitus | Q36626417 | ||
| Greek hyperinsulinemic women, with or without polycystic ovary syndrome, display altered inositols metabolism | Q37310914 | ||
| Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease | Q37742798 | ||
| Second messengers of insulin action | Q37850168 | ||
| Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance | Q38296483 | ||
| Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study | Q38323835 | ||
| Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome | Q41261033 | ||
| Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications | Q41482748 | ||
| Transport in isolated rat hepatocytes of the phospho-oligosaccharide that mimics insulin action. Effects of adrenalectomy and glucocorticoid treatment | Q42150490 | ||
| Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens | Q42448141 | ||
| Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome | Q42519459 | ||
| 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss | Q42529057 | ||
| Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial | Q43571603 | ||
| P433 | issue | 2 | |
| P921 | main subject | obesity | Q12174 |
| polycystic ovary syndrome | Q500816 | ||
| polycystic ovary | Q5547896 | ||
| P304 | page(s) | 127-136 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | Metabolic syndrome and related disorders | Q26842408 |
| P1476 | title | Uncoupling between insulin and release of a D-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women With polycystic ovary syndrome | |
| P478 | volume | 8 |
| Q34546109 | Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients |
| Q46085298 | Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial |
| Q97530770 | Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: study protocol for a randomized controlled trial |
| Q37303239 | Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome. |
| Q47755753 | Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis |
| Q28073603 | Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials |
| Q28077261 | Inositol Treatment and ART Outcomes in Women with PCOS |
| Q34557177 | Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials |
| Q30413667 | Inositol, glycogen, insulin, and six nobelists |
| Q97524388 | Inositols and metabolic disorders: From farm to bedside |
| Q60947914 | Inositols in Insulin Signaling and Glucose Metabolism |
| Q28072521 | Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk |
| Q94322504 | Interventions for preventing gestational diabetes mellitus: an overview of Cochrane Reviews |
| Q37579255 | Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome |
| Q38879505 | Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease |
| Q41653290 | Pioglitazone Therapy Increases Insulin-Stimulated Release of d-Chiro-Inositol-Containing Inositolphosphoglycan Mediator in Women with Polycystic Ovary Syndrome |
| Q33775146 | Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols |
| Q36249324 | Primary prevention of gestational diabetes mellitus through nutritional factors: a systematic review |
| Q35818880 | Relationship Between Myo-Inositol Supplementary and Gestational Diabetes Mellitus: A Meta-Analysis |
| Q37502964 | The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry). |
| Q47928353 | The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment |
| Q34026140 | The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes |
| Q55257913 | The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. |
| Q28248914 | The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study |
| Q51304321 | d-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS. |
Search more.